BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4913961)

  • 1. Controlled clinical trial of ergotamine tartrate.
    Waters WE
    Br Med J; 1970 May; 2(5705):325-7. PubMed ID: 4913961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolfenamic acid is as effective as ergotamine during migraine attacks.
    Hakkarainen H; Vapaatalo H; Gothoni G; Parantainen J
    Lancet; 1979 Aug; 2(8138):326-8. PubMed ID: 89390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine.
    Dahlöf C
    Cephalalgia; 1993 Jun; 13(3):166-71. PubMed ID: 8358774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of ergotamine tartrate.
    Waters WE
    Br J Prev Soc Med; 1970 Feb; 24(1):65. PubMed ID: 4908199
    [No Abstract]   [Full Text] [Related]  

  • 5. Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound.
    Hakkarainen H; Quiding H; Stockman O
    J Clin Pharmacol; 1980 Oct; 20(10):590-5. PubMed ID: 7440766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache.
    Ryan RE
    Headache; 1970 Jan; 9(4):212-20. PubMed ID: 4904954
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks.
    Kinnunen E; Erkinjuntti T; Färkkilä M; Palomäki H; Porras J; Teirmaa H; Freudenthal Y; Andersson P
    Cephalalgia; 1988 Sep; 8(3):175-9. PubMed ID: 3143482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neosal, ergotamine tartrate caffeine and placebo in acute migraine attack].
    Klapetek J
    Med Welt; 1973 May; 24(18):745-7. PubMed ID: 4574382
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound.
    Pradalier A; Rancurel G; Dordain G; Verdure L; Rascol A; Dry J
    Cephalalgia; 1985 Jun; 5(2):107-13. PubMed ID: 3926322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks.
    Treves TA; Streiffler M; Korczyn AD
    Headache; 1992 Jun; 32(6):280-2. PubMed ID: 1399547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
    Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group.
    Eur Neurol; 1991; 31(5):314-22. PubMed ID: 1653139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the treatment of migrainous neuralgia.
    Mann P; Sutherland JM; Eadie MJ
    Proc Aust Assoc Neurol; 1970; 7():49-53. PubMed ID: 5514825
    [No Abstract]   [Full Text] [Related]  

  • 17. Spasm of arm arteries due to ergotamine tartrate. A case report.
    Palombo D; Mirelli M; Peinetti F; Porta C; Brustia P; Udini M
    Int Angiol; 1991; 10(1):51-3. PubMed ID: 2071975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ergotamine tartrate in the treatment of migraine.
    Wilkinson M; Wall WC
    Arch Neurobiol (Madr); 1974; 37 SUPPL():317-9. PubMed ID: 4462488
    [No Abstract]   [Full Text] [Related]  

  • 19. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergotamine tartrate in migraine and the dangers of overdose.
    Wall MC
    Nurs Times; 1972 Dec; 68(50):1585. PubMed ID: 4640242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.